← Leaderboards
Yuhong Yang
Ohio State University
$642,122
Attributed
$1,284,243
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $471.1K · FY2015–17$500K$375K$250K$125K$0
'15
'16
'17
Funding mix
By agency
NIH$1,284,243 · 1
By mechanism
R01$1,284,243 · 1
Top collaborators
- Chenglong Li4 shared
Most similar at Ohio State University
Same institution · by research overlap
- Amy E Lovett-Racke$7,052,190
- Daniel R. Schoenberg$10,326,959
- Susan R Mallery$15,292,540
- Krystof S Bankiewicz$27,032,201
- Michael C Ostrowski$13,472,116
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignDimerizationCytokineAutoimmunityAutopsyAdoptive TransferComplexAdultBiological AvailabilityBiopsyBlocking AntibodiesBrain TissueC57bl/6 MouseBaseAutoimmune DiseasesCd4 Positive T LymphocytesCell Culture TechniquesCellsChemistryChronicClinicClinical ResearchColonDisability
Grant awards (4)
Small molecule in vivo probe development targeting the IL-6/STAT3 pathway for potential multiple sclerosis therapy$342,568
R01 · FY2017 · NS
Small molecule in vivo probe development targeting the IL-6/STAT3 pathway for potential multiple sclerosis therapy$330,037
R01 · FY2016 · NS
Small molecule in vivo probe development targeting the IL-6/STAT3 pathway for potential multiple sclerosis therapy$140,524
R01 · FY2016 · NS
Small molecule in vivo probe development targeting the IL-6/STAT3 pathway for potential multiple sclerosis therapy$471,114
R01 · FY2015 · NS